Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry

Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry

Abstract There is little data describing trends in the use of hydroxychloroquine for COVID-19 following publication of randomized trials that failed to demonstrate a benefit of this therapy. We identified 13,957 patients admitted for active COVID-19 at 85 U.S. hospitals participating in a national r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Steven M. Bradley, Sophia Emmons-Bell, R. Kannan Mutharasan, Fatima Rodriguez, Divya Gupta, Gregory Roth, Ty J. Gluckman, Rashmee U. Shah, Tracy Y. Wang, Rohan Khera, Pamela N. Peterson, Sandeep Das
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/86e2f28a42fa4d5789e3d0e70e0830b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/86e2f28a42fa4d5789e3d0e70e0830b6

Ejemplares similares